AKERNA CORP (KERN)
US00973W3007 - Common Stock
We assign a fundamental rating of 0 out of 10 to KERN. KERN was compared to 276 industry peers in the Software industry. Both the profitability and financial health of KERN have multiple concerns. KERN has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year KERN has reported negative net income.
In the past year KERN has reported a negative cash flow from operations.
In the past 5 years KERN always reported negative net income.
KERN had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
KERN's Return On Assets of -821.29% is on the low side compared to the rest of the industry. KERN is outperformed by 98.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -821.29% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-156.88%
ROA(5y)-120.86%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
KERN's Gross Margin of 56.92% is on the low side compared to the rest of the industry. KERN is outperformed by 61.37% of its industry peers.
KERN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for KERN so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 56.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.77%
GM growth 5Y-4.94%
2. Health
2.1 Basic Checks
KERN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for KERN has been increased compared to 1 year ago.
Compared to 5 years ago, KERN has more shares outstanding
The debt/assets ratio for KERN is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -66.44, we must say that KERN is in the distress zone and has some risk of bankruptcy.
KERN's Altman-Z score of -66.44 is on the low side compared to the rest of the industry. KERN is outperformed by 97.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -66.44 |
ROIC/WACCN/A
WACC3.75%
2.3 Liquidity
A Current Ratio of 0.10 indicates that KERN may have some problems paying its short term obligations.
KERN's Current ratio of 0.10 is on the low side compared to the rest of the industry. KERN is outperformed by 98.56% of its industry peers.
KERN has a Quick Ratio of 0.10. This is a bad value and indicates that KERN is not financially healthy enough and could expect problems in meeting its short term obligations.
KERN's Quick ratio of 0.10 is on the low side compared to the rest of the industry. KERN is outperformed by 98.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.1 | ||
| Quick Ratio | 0.1 |
3. Growth
3.1 Past
KERN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.46%, which is quite impressive.
The Revenue for KERN has decreased by -31.66% in the past year. This is quite bad
Measured over the past years, KERN shows a quite strong growth in Revenue. The Revenue has been growing by 19.51% on average per year.
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q76.47%
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y19.51%
Revenue growth Q2Q-32.03%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y95.9%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-57.91%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for KERN. In the last year negative earnings were reported.
Also next year KERN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for KERN!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
AKERNA CORP
NASDAQ:KERN (2/8/2024, 7:00:03 PM)
After market: 0.364 +0.05 (+16.07%)0.3136
+0.08 (+36.94%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.25M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -821.29% | ||
| ROE | N/A | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 56.92% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.1 | ||
| Quick Ratio | 0.1 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)83.46%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y95.9%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-31.66%
Revenue growth 3Y8.05%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y